RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.

Add to Collection
2011 Apr Others Fist_Author_Year_PM

Full Author : ['Pratley, R', 'Nauck, M', 'Bailey, T', 'Montanya, E', 'Cuddihy, R', 'Filetti, S', 'Garber, A', 'Thomsen, A B', 'Hartvig, H', 'Davies, M']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2011
Cited by : Not Available

AIM: The aim of this study was to compare the efficacy and safety of once-daily human glucagon-like peptide-1 analogue liraglutide with dipeptidyl peptidase-4 inhibitor sitagliptin, each added to metformin, over 52 weeks in individuals with type 2 diabete.....

Keywords : ["randomised parallelgroup openlabel trial", "liraglutide treatment offer sustain", "weight reduction compare", "effective glycaemic control", "type diabetes", "one year", "sitagliptin", "patient", "metformin", "combination"]